Healthcare provider profile · identity verified

Deepti Shivakumar, MD

Family Practice · MELROSE PARK, IL · NPI 1023221157

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	382	115
Amlodipine Besylate	Amlodipine Besylate	355	112
Lisinopril	Lisinopril	258	71
Metformin Hcl	Metformin Hcl	230	65
Levothyroxine Sodium	Levothyroxine Sodium	189	50
Losartan Potassium	Losartan Potassium	163	51
Hydrochlorothiazide	Hydrochlorothiazide	148	47
Rosuvastatin Calcium	Rosuvastatin Calcium	131	43
Albuterol Sulfate Hfa	Albuterol Sulfate	122	29
Metoprolol Succinate	Metoprolol Succinate	117	35
Simvastatin	Simvastatin	116	33
Pantoprazole Sodium	Pantoprazole Sodium	113	36
Alendronate Sodium	Alendronate Sodium	94	25
Omeprazole	Omeprazole	82	23
Tramadol Hcl	Tramadol Hcl	80	12
Gabapentin	Gabapentin	73	27
Furosemide	Furosemide	69	31
Sertraline Hcl	Sertraline Hcl	66	16
Fluticasone Propionate	Fluticasone Propionate	59	24
Carvedilol	Carvedilol	53	16
Potassium Chloride	Potassium Chloride	52	19
Pregabalin	Pregabalin	52	suppressed
Chlorthalidone	Chlorthalidone	50	15
Metoprolol Tartrate	Metoprolol Tartrate	50	15
Eliquis	Apixaban	49	13
Allopurinol	Allopurinol	47	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	47	15
Clopidogrel	Clopidogrel Bisulfate	45	15
Mounjaro	Tirzepatide	40	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	12
Ozempic	Semaglutide	39	suppressed
Farxiga	Dapagliflozin Propanediol	37	suppressed
Enalapril Maleate	Enalapril Maleate	35	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Trazodone Hcl	Trazodone Hcl	35	suppressed
Alprazolam	Alprazolam	34	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Meloxicam	Meloxicam	34	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	11
Zolpidem Tartrate	Zolpidem Tartrate	29	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Olanzapine	Olanzapine	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	13
Propranolol Hcl	Propranolol Hcl	24	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Ventolin Hfa	Albuterol Sulfate	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Spironolactone	Spironolactone	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Citalopram Hbr	Citalopram Hydrobromide	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Cephalexin	Cephalexin	16	14
Ezetimibe	Ezetimibe	16	suppressed
Methylprednisolone	Methylprednisolone	16	12
Nifedipine Er	Nifedipine	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Jardiance	Empagliflozin	15	suppressed
Linzess	Linaclotide	15	suppressed
Valsartan	Valsartan	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	14	14
Glimepiride	Glimepiride	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Famotidine	Famotidine	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Atenolol	Atenolol	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Estradiol	Estradiol	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Glipizide	Glipizide	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Nystatin	Nystatin	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error